Resilience Care Expands Digital Oncology Offering Into U.S. Market

According to a recent LinkedIn post from Resilience Care, the company is beginning a new phase of activity in the U.S. market, building on its work with oncology teams across France and Europe. The post highlights that its digital oncology solution for Remote Therapeutic Monitoring has been implemented in more than 200 cancer centers and has supported over 35,000 patients.

The company’s LinkedIn post also indicates a U.S. leadership build-out, with Greg Orr, formerly COO of Jasper Health and VP of Digital Health at Walgreens, taking the role of General Manager U.S. An advisory board comprising digital health and oncology veterans, including Eddie Martucci, Jill DeSimone, Anne Ireland and Ethan Basch, is described as supporting this expansion.

For investors, the move suggests a strategic push into the large and reimbursement-driven U.S. oncology and digital health market, where remote monitoring and patient-reported outcomes are gaining regulatory and payer traction. If Resilience Care can leverage its European track record and leadership expertise to secure partnerships with U.S. providers and payers, it could open new recurring revenue streams and enhance the firm’s competitive positioning.

The advisory board composition, as outlined in the post, points to a focus on evidence-based care, commercialization and clinical workflow integration, which are key barriers to adoption in digital oncology. However, the expansion may also entail higher upfront commercial and regulatory costs, and success will likely depend on differentiation in a crowded field of digital health platforms targeting oncology and chronic care management.